MEK inhibition causes BIM stabilization and increased sensitivity to BCL-2 family member inhibitors in RAS-MAPK-mutated neuroblastoma

INTRODUCTION: Mutations affecting the RAS-MAPK pathway occur frequently in relapsed neuroblastoma tumors and are associated with response to MEK inhibition in vitro. However, these inhibitors alone do not lead to tumor regression in vivo, indicating the need for combination therapy. METHODS AND RESU...

Descripción completa

Detalles Bibliográficos
Autores principales: Eleveld, Thomas F., Vernooij, Lindy, Schild, Linda, Koopmans, Bianca, Alles, Lindy K., Ebus, Marli E., Dandis, Rana, van Tinteren, Harm, Caron, Huib N., Koster, Jan, van Noesel, Max M., Tytgat, Godelieve A. M., Eising, Selma, Versteeg, Rogier, Dolman, M. Emmy M., Molenaar, Jan J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9990464/
https://www.ncbi.nlm.nih.gov/pubmed/36895472
http://dx.doi.org/10.3389/fonc.2023.1130034

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9990464/
https://www.ncbi.nlm.nih.gov/pubmed/36895472
http://dx.doi.org/10.3389/fonc.2023.1130034

Ejemplares similares